Enzon Pharmaceuticals Inc (NASDAQ:ENZN), a company in the business of licensing drug products, usually would not be on the radar of the investors but a rise of 77% in the current month definitely makes it a name worthy of some attention. The last trading session saw an insane number of shares changing hands, pushing the volume for the day to 35 million which was huge compared to the daily average of 3 million only. The stock had opened with a gap down but in the closing hours, the bulls took the control and ended the session with a gain of 13%.
Enzon Pharmaceuticals Inc (NASDAQ:ENZN) rose over 32% in the last 12 months, outperforming the broader indices by a huge margin. The probable reason for that strong performance comes from the improved financials of the company like the last reported quarterly earnings per share seeing an increase of 8.3% compared to the same quarter in the previous year. The bottom line improved from $0.39 to $0.65. The revenue dropped by 15.6% compared to the same quarter in the previous year, a serious underperformance compared to the industry average of 35.1%. Still, the improved earnings per share saved the bottom line from being hurt by the declining revenue.
Technically, the major trend for the stock has been nothing but down in the last few years but the bearish momentum has slowed down a lot in the last 1 year. The stock is stuck in the range of $0.80-$1.90 for a long time and as long as the stock closes below $1.90, the investors actually can’t hope for much. The record volume seen in the last trading session has definitely interested the market participants but it will become meaningless below $1.90. Cautious investors may keep an eye on the stock and wait for a firm closing before taking positions.
